Position in VTGN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$5,980
-$8,840 QoQ
Shares Held
26,000
0.0% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 4 holders
Holding Since
Sep 2024
8 quarters on record
Common Shares in VTGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kestra Advisory Services, LLC holds $29,012,263 across 51 Biotechnology names. VTGN ranks #50 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,732 | $7,814,556 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,893 | $1,803,901 | |
| 3 | RPRX |
Royalty Pharma plc
|
27,331 | $1,532,449 | |
| 4 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
39,421 | $1,239,002 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
27,091 | $1,056,819 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
110,630 | $968,565 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
10,914 | $948,972 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
17,292 | $943,105 |
All Filings in VTGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,980 | 26,000 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $14,820 | 26,000 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $17,181 | 26,033 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $71,117 | 20,033 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $40,066 | 20,033 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $50,082 | 20,033 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $59,342 | 20,116 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $60,299 | 20,033 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||